tiprankstipranks
Trending News
More News >
Drugs Made In America Acquisition Corp. (DMAA)
NASDAQ:DMAA
US Market

Drugs Made In America Acquisition Corp. (DMAA) Income Statement

Compare
2 Followers

Drugs Made In America Acquisition Corp. Income Statement

Last quarter (Q4 2024), Drugs Made In America Acquisition Corp.'s total revenue was $0.00, a decrease of ― from previous quarter. In Q4, Drugs Made In America Acquisition Corp.'s net income was $―. See Drugs Made In America Acquisition Corp.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24
Total Revenue
$ 0.00
Gross Profit
$ 0.00
Operating Expenses
-
Depreciation and Amortization
-
EBITDA
$ 0.00
Operating Income
-
Other Income/Expenses
$ 0.00
Pretax Income
-
Net Income
-
Per Share Metrics
Basic EPS
$ -0.06
Diluted EPS
$ -0.06
Weighted Average Shares Outstanding
8.57K
Weighted Average Shares Outstanding (Diluted)
-
Currency in USD

Drugs Made In America Acquisition Corp. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis